Daitoku Sakamuro
Affiliations: | Medicinal Chemistry and Molecular Pharmacology | Purdue University, West Lafayette, IN, United States |
Area:
Cell BiologyGoogle:
"Daitoku Sakamuro"Mean distance: (not calculated yet)
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Folk WP, Kumari A, Iwasaki T, et al. (2021) New Synthetic Lethality Re-Sensitizing Platinum-Refractory Cancer Cells to Cisplatin In Vitro: The Rationale to Co-Use PARP and ATM Inhibitors. International Journal of Molecular Sciences. 22 |
| Folk WP, Kumari A, Iwasaki T, et al. (2019) Loss of the tumor suppressor BIN1 enables ATM Ser/Thr kinase activation by the nuclear protein E2F1 and renders cancer cells resistant to cisplatin. The Journal of Biological Chemistry |
| Fernung LP, Yang Q, Sakamuro D, et al. (2018) Endocrine Disruptor Exposure during Development Increases Incidence of Uterine Fibroids by Altering DNA Repair in Myometrial Stem Cells. Biology of Reproduction |
| Kumari A, Folk WP, Sakamuro D. (2017) The Dual Roles of MYC in Genomic Instability and Cancer Chemoresistance. Genes. 8 |
| Kumari A, Iwasaki T, Folk WP, et al. (2016) Abstract PR09: c-MYC preserves genomic integrity during DNA replication: a paradigm shift of c-MYC Molecular Cancer Research. 14 |
| Folk WP, Kumari A, Cassimere E, et al. (2016) Abstract B03: Physical and functional interactions between two tumor suppressors, BIN1 and RB1 Molecular Cancer Research. 14 |
| Pyndiah S, Sakamuro D. (2015) Restoration of tumor suppressor functions by small-molecule inhibitors. Molecular & Cellular Oncology. 2: e991225 |
| Sakamuro D, Folk WP, Kumari A. (2015) To die, or not to die: E2F1 never decides by itself during serum starvation. Molecular & Cellular Oncology. 2: e981447 |
| Kumari A, Iwasaki T, Pyndiah S, et al. (2015) Regulation of E2F1-induced apoptosis by poly(ADP-ribosyl)ation. Cell Death and Differentiation. 22: 311-22 |
| Pyndiah S, Sakamuro D. (2013) [c-MYC, PARP1 and BIN1 as targets for therapy of cancer cell resistance]. MéDecine Sciences : M/S. 29: 133-5 |